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Commentary
In recent years, clinical assisted reproduction techniques
(ART) are increasingly being practiced worldwide, which
in turn has led to an accumulated surplus of cryopreserved
embryos within fertility clinics [1,2]. Nevertheless, in
those countries where the commercialization of embryo
donation is banned – and former ART patients are
expected to donate their cryopreserved supernumerary
embryos altruistically to infertile couples – the resultant
effect is often severe shortages and long waiting lists for
prospective recipients [3]. Couples who have attained suc-
cess in clinical assisted reproduction are usually reluctant
to donate their cryopreserved supernumerary embryos to
other couples [4]. This is because frozen embryos are psy-
chologically conceptualized by former patients as biologic
tissue, living entities, 'virtual' children having interests
that must be considered and protected, siblings of their
living children, genetic or psychological 'insurance poli-
cies', and symbolic reminders of their past infertility [5].
Under such circumstances, whereby legally donated
embryos are in such short supply and high demand, med-
ical professionals and health institutions can easily
exploit the situation for profiteering in medical fees, par-
ticularly if they possess exclusive rights of distribution of
the donated embryos to prospective recipients.
Although such institutions are not permitted to directly
profit from the transaction of cryopreserved embryos
between donor and recipient, it must be remembered that
there is still considerable opportunity for profiteering in
medical fees arising from laboratory and clinical services
rendered to the recipient. It is easy to disguise the 'sale' of
altruistically donated human embryos through substan-
tially increased medical fees, particularly in a private prac-
tice setting. Firstly, patients seeking treatment at privately
run IVF programs are already prepared to pay higher med-
ical fees for the supposedly 'better' reputation of the fertil-
ity doctor and 'enhanced' medical facilities available.
Secondly, it is often the case that patients seeking donated
embryos at a privately-run fertility clinic have already
been exasperated by the long waiting list of government-
funded IVF programs, and therefore would have no
qualms with paying higher medical fees. Lastly, a privately
run IVF program would usually treat the medical fees
charged to individual patients as confidential informa-
tion. Hence, it is difficult for patients to discern whether
there is any disparity in medical fees for a self- and donor-
freeze/thaw embryo transfer cycle, which could, in fact,
mask 'opportunistic profiteering' by medical profession-
als.
Therefore, the pertinent question that arises is, what
would constitute a fair and honest profit margin for the
medical professional and health institution in question? A
suitable benchmark would obviously be the level of med-
ical fees normally charged to patients for a self-freeze/
thaw embryo transfer cycle, after initial failure at their first
attempt in ART. This is because the level of medical exper-
tise, clinical and laboratory services required for a donor-
and self-freeze/thaw embryo transfer cycle should, in the-
ory, be about the same [6], although slight variation in
treatment can be expected owing to patients' respective
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medical histories, which results in varying predisposition
to medical complications. In any case, the health author-
ity should ensure that there is no gross disparity in the
medical fees for both donor- and self-freeze/thaw embryo
transfer cycle, as this could mask opportunistic profiteer-
ing by medical professionals and, in fact, be a covert form
of embryo commercialization.
There is nothing deplorable about profit-making in
healthcare services – after all, medical professionals ought
to make a decent living after numerous years of expensive
education, coupled with their heavy investment in medi-
cal equipment and facilities. Nevertheless, it is imperative
that they should always work towards a fair and honest
profit margin, rather than exploit the short supply of
legally donated human material for financial gain. It must
always be remembered that the embryo donor has pre-
sumably been altruistically, rather than financially, moti-
vated to help the recipient; such opportunistic
profiteering by medical professionals would be an
extreme breach of medical ethics and professional code of
conduct, particularly if they are encouraging their former
patients to altruistically donate supernumerary embryos
for the sake of infertile couples. It must be noted that
many childless couples feel a sense of exhilaration and
euphoric joy upon attaining success in clinical assisted
reproduction. This altered emotional state could render
them particularly vulnerable to the coaxing of medical
professionals, to whom they feel they owe a debt of grati-
tude [7].
Another solution for greater transparency would be to
establish a government-controlled national or regional
register of prospective embryo donors and recipients, one
successful example being CECOS in France [8]. This
would then facilitate a more equitable distribution of
donated embryos to prospective recipients based on med-
ical condition and needs, rather than choice of medical
doctor and health institution for treatment, the latter pro-
viding much room for abuse and opportunistic profiteer-
ing.
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